Bionovate Technologies Debt 2024

Bionovate Technologies Aktienanalyse

What does Bionovate Technologies do?

Bionovate Technologies Corp is a biotechnology company specializing in the research, development, and marketing of innovative medical devices for the diagnosis and treatment of skin diseases. It was founded in 2017 and is headquartered in Vancouver, Canada. Bionovate Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Bionovate Technologies's Debt Structure

Bionovate Technologies's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Bionovate Technologies's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Bionovate Technologies’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Bionovate Technologies’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Bionovate Technologies stock

What is the debt of Bionovate Technologies this year?

Bionovate Technologies has a debt level of 0.19 USD this year.

What was the debt of Bionovate Technologies compared to the previous year?

The debt of Bionovate Technologies has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Bionovate Technologies?

High debt can pose a risk for investors of Bionovate Technologies, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Bionovate Technologies?

Low debt means that Bionovate Technologies has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Bionovate Technologies affect the company?

An increase in debt of Bionovate Technologies can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Bionovate Technologies affect the company?

A reduction in debt of Bionovate Technologies can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Bionovate Technologies?

Some factors that can influence the debt of Bionovate Technologies include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Bionovate Technologies so important for investors?

The debts of Bionovate Technologies are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Bionovate Technologies take to change the debt?

To change the debt, Bionovate Technologies can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Bionovate Technologies pay?

Over the past 12 months, Bionovate Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bionovate Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Bionovate Technologies?

The current dividend yield of Bionovate Technologies is .

When does Bionovate Technologies pay dividends?

Bionovate Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bionovate Technologies?

Bionovate Technologies paid dividends every year for the past 0 years.

What is the dividend of Bionovate Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bionovate Technologies located?

Bionovate Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bionovate Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bionovate Technologies from 9/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Bionovate Technologies pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Bionovate Technologies in the year 2023?

In the year 2023, Bionovate Technologies distributed 0 USD as dividends.

In which currency does Bionovate Technologies pay out the dividend?

The dividends of Bionovate Technologies are distributed in USD.